Canadian Cancer Trials Group Bulletins


Canadian Cancer Trials Group Name and Logo

As many of you will know, on June 12, 2008, the National Cancer Institute of Canada (NCIC) Board of Directors voted unanimously in favour of integrating the NCIC with the Canadian Cancer Society (CCS). Within the CCS, there was a strong sense that its research activity should have a name that would resonate with both donors and the research community. After a consultation process that included CCS and NCIC board members, other scientists and CCS representatives, the name selected was The Canadian Cancer Society Research Institute (CCSRI).

This, obviously, has implications for our name -- the Canadian Cancer Trials Group. On one hand, part of this name -- the NCIC -- will no longer exist. On the other hand, our Group has a history, international reputation and branding that is associated with "Canadian Cancer Trials Group". After much discussion, it was determined that we will continue to be known as the "Canadian Cancer Trials Group" or "Canadian Cancer Trials Group". This decision may be revisited over the next year but, for now, we are very pleased and grateful that this remains our name. However, while we will continue to use "NCIC", we will be eliminating the full text "National Cancer Institute of Canada", thus ensuring we are known as the "Canadian Cancer Trials Group" or "Canadian Cancer Trials Group". We will effect this change as of February 1, 2009.

Also, as of February 1, 2009, we will be abandoning our logo. An alternative logo that accounts for our relation with CCS will be developed in concert with them. Until then, we will use only a text logo that in English says "Canadian Cancer Trials Group" and in French is "NCIC GEC":

Over the next months, we will be systematically reviewing and updating trial documents, websites, presentation/poster templates, etc. to reflect our new name and logo and eliminate references to the "National Cancer Institute of Canada". At this time, we would ask that our members also ensure that any references to the "National Cancer Institute of Canada Clinical Trials Group" included on trial documents and such materials as slide sets, news articles/ promotional materials, websites etc. be replaced with "Canadian Cancer Trials Group". Additionally, we would appreciate you bringing to our attention any references to the National Cancer Institute of Canada that we may have overlooked.

We will continue to keep you abreast of any further developments and about our progress as we move along. If you have any questions about this, please do not hesitate to contact Belinda Vandersluis, Operations Director, at or (613) 533-6430.

We appreciate your cooperation and your efforts to assist us with this transition.